1. Home
  2. NRXP vs BOF Comparison

NRXP vs BOF Comparison

Compare NRXP & BOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • BOF
  • Stock Information
  • Founded
  • NRXP 2015
  • BOF 2017
  • Country
  • NRXP United States
  • BOF United States
  • Employees
  • NRXP N/A
  • BOF N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • BOF Packaged Foods
  • Sector
  • NRXP Health Care
  • BOF Consumer Staples
  • Exchange
  • NRXP Nasdaq
  • BOF Nasdaq
  • Market Cap
  • NRXP 14.8M
  • BOF 12.5M
  • IPO Year
  • NRXP N/A
  • BOF 2023
  • Fundamental
  • Price
  • NRXP $1.16
  • BOF $1.97
  • Analyst Decision
  • NRXP Strong Buy
  • BOF
  • Analyst Count
  • NRXP 3
  • BOF 0
  • Target Price
  • NRXP $31.33
  • BOF N/A
  • AVG Volume (30 Days)
  • NRXP 153.3K
  • BOF 694.1K
  • Earning Date
  • NRXP 11-18-2024
  • BOF 11-19-2024
  • Dividend Yield
  • NRXP N/A
  • BOF N/A
  • EPS Growth
  • NRXP N/A
  • BOF N/A
  • EPS
  • NRXP N/A
  • BOF N/A
  • Revenue
  • NRXP N/A
  • BOF $5,215,452.00
  • Revenue This Year
  • NRXP N/A
  • BOF N/A
  • Revenue Next Year
  • NRXP N/A
  • BOF N/A
  • P/E Ratio
  • NRXP N/A
  • BOF N/A
  • Revenue Growth
  • NRXP N/A
  • BOF 703.78
  • 52 Week Low
  • NRXP $1.10
  • BOF $0.61
  • 52 Week High
  • NRXP $7.33
  • BOF $4.11
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 33.72
  • BOF 60.04
  • Support Level
  • NRXP $1.23
  • BOF $1.72
  • Resistance Level
  • NRXP $1.30
  • BOF $2.20
  • Average True Range (ATR)
  • NRXP 0.10
  • BOF 0.14
  • MACD
  • NRXP 0.00
  • BOF 0.04
  • Stochastic Oscillator
  • NRXP 12.12
  • BOF 66.18

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About BOF BranchOut Food Inc.

Branchout Food inc is engaged in the development, marketing, sale, and distribution of plant-based, dehydrated fruit and vegetable snacks and powders. Its products are currently manufactured for the company by contract manufacturers based in South America and North America that produce dehydrated fruit and vegetable products for the company using a new proprietary dehydration technology that it licenses from a third party. The Company's customers are primarily located throughout the United States. Its current primary products are BranchOut Snacks, BranchOut Powders, and BranchOut Industrial Ingredients.

Share on Social Networks: